NasdaqGS - Nasdaq Real Time Price USD

Cabaletta Bio, Inc. (CABA)

10.67 -0.25 (-2.29%)
At close: 4:00 PM EDT
10.94 +0.27 (+2.53%)
After hours: 4:58 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Expense
85,735.00
74,660.00
54,139.00
46,313.00
33,833.00
--
Operating Income
-85,735.00
-74,660.00
-54,139.00
-46,313.00
-33,833.00
--
Net Non Operating Interest Income Expense
8,867.00
6,985.00
1,164.00
24.00
494.00
--
Pretax Income
-76,868.00
-67,675.00
-52,975.00
-46,289.00
-33,339.00
--
Net Income Common Stockholders
-76,868.00
-67,675.00
-52,975.00
-46,289.00
-33,339.00
--
Diluted NI Available to Com Stockholders
-76,966.00
-67,675.00
-52,975.00
-46,289.00
-33,339.00
--
Basic EPS
-1.71
--
-1.81
-1.80
-1.44
-4.07
Diluted EPS
-1.71
--
-1.81
-1.80
-1.44
-4.07
Basic Average Shares
42,759.99
--
26,014.16
21,360.54
23,152.08
24,034.02
Diluted Average Shares
44,409.38
--
29,342.91
25,737.32
23,152.08
24,034.02
Total Operating Income as Reported
-85,735.00
-74,660.00
-54,139.00
-46,313.00
-33,833.00
--
Total Expenses
85,735.00
74,660.00
54,139.00
46,313.00
33,833.00
--
Net Income from Continuing & Discontinued Operation
-76,868.00
-67,675.00
-52,975.00
-46,289.00
-33,339.00
--
Normalized Income
-76,868.00
-67,675.00
-52,975.00
-46,289.00
-33,339.00
--
Interest Income
8,867.00
6,985.00
1,164.00
24.00
494.00
--
Net Interest Income
8,867.00
6,985.00
1,164.00
24.00
494.00
--
EBIT
-85,735.00
-74,660.00
-54,139.00
-46,313.00
-33,833.00
--
EBITDA
-84,281.00
-73,234.00
-52,961.00
-45,580.00
-33,479.00
--
Reconciled Depreciation
1,454.00
1,426.00
1,178.00
733.00
354.00
--
Net Income from Continuing Operation Net Minority Interest
-76,868.00
-67,675.00
-52,975.00
-46,289.00
-33,339.00
--
Normalized EBITDA
-84,281.00
-73,234.00
-52,961.00
-45,580.00
-33,479.00
--
12/31/2019 - 10/25/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KYTX Kyverna Therapeutics, Inc.
13.23
+1.77%
 
PLRX Pliant Therapeutics, Inc.
12.88
+1.18%
 
NKTX Nkarta, Inc.
6.47
+0.47%
 
STOK Stoke Therapeutics, Inc.
14.07
-2.39%
 
SANA Sana Biotechnology, Inc.
7.80
-2.74%
 
AKRO Akero Therapeutics, Inc.
19.50
+6.44%
 
ALXO ALX Oncology Holdings Inc.
12.56
-4.63%
 
IMTX Immatics N.V.
11.67
-0.26%
 
CRNX Crinetics Pharmaceuticals, Inc.
46.86
-1.29%
 
IMCR Immunocore Holdings plc
46.30
+0.54%